troloxamide

Small moleculeexperimental

Clinical trial activity

2 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2015 (NCT02460679)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • epi-589
  • epi-589

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02462603Phase 2Mar 1, 2016Bioelectron
NCT02460679Phase 2Dec 1, 2015Bioelectron
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BioelectronFor profit2212015
1 organizations
Page 1 / 1